🐢 **Dataroma: Boston Scientific Insider Buying Continues Into Early August, Topped by a $9M Purchase**

Boston Scientific insiders filed purchases on four separate days over the past week, including a **$9M** single buy on Aug 5 — the newest filing on Dataroma's insider tracker is dated **Aug 7**.
• Schroders and BlackRock stay constructive on equities into H2 on earnings momentum, but both flag _pockets of froth_ and stretched valuations in parts of the market.
• PIMCO's caution on return dispersion and geopolitical fragmentation reinforces the case for large, high-quality names less exposed to macro cross-currents.

**💡 Why it matters:** Repeated insider buying at a large-cap medtech name while major asset managers flag valuation froth elsewhere may point to rotation toward defensive, earnings-visible sectors rather than a broad re-rating of risk appetite.

[🔗 Read more](/leaving?url=aHR0cHM6Ly93d3cuZGF0YXJvbWEuY29tL20vaG9tZS5waHA=)
[#dataroma](/search?q=%23dataroma)